<DOC>
	<DOCNO>NCT02927184</DOCNO>
	<brief_summary>This study investigate efficacy , safety , tolerability VK2809 lower LDL-C liver fat content patient primary hypercholesterolemia fatty liver disease . The primary efficacy endpoint percent change baseline LDL-C end treatment period ( Week 12 ) . Secondary endpoint include effect liver fat content liver lipid marker , well effect safety tolerability , pharmacokinetic ( PK ) measurement .</brief_summary>
	<brief_title>Safety Tolerability VK2809 Patients With Primary Hypercholesterolemia Non-Alcoholic Fatty Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>1 . Minimum 10 % liver fat assess MRI Proton Density Fat Fraction 2 . Fasting serum LDLC &gt; 130 mg/dL screening , &gt; 110 mg/dL lipid lower medication 3 . Any one following : 1 . Triglycerides ≥150 mg/dL receive prescription medication elevate triglyceride . 2 . Systolic blood pressure &gt; 130 mmHg diastolic blood pressure ≥85 mmHg receive prescription medication hypertension . 3 . Waist circumference &gt; 40 inch ( men ) &gt; 35 inch ( woman ) 4 . Body mass index ( BMI ) 18.50 40.00 kg/m2 inclusive screen 5 . Provide personallysigned date informed consent document 1 . Females childbearing potential male unwilling use barrier birth control method ( condom ) throughout study 2 . Resting 12lead ECG show QTc &gt; 450 msec , tachyarrhythmia morphology change , clinically significant abnormality 3 . Cardiovascular event require hospitalization past year 4 . History presence thyroid disorder 5 . History malignancy past 5 year 6 . LDLC ≥190 mg/dL familial hypercholesterolemia 7 . Significant hepatic renal function test abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>